Cargando…

Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma

Detalles Bibliográficos
Autores principales: Li, Tingting, Zhang, Xiaoyue, Wang, Caroline, Jia, Qiuyu, Zhong, Lingzhi, Hu, Jian, Li, Houmin, Zhang, Jianzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617823/
https://www.ncbi.nlm.nih.gov/pubmed/37036897
http://dx.doi.org/10.1097/CM9.0000000000002599
_version_ 1785129658239418368
author Li, Tingting
Zhang, Xiaoyue
Wang, Caroline
Jia, Qiuyu
Zhong, Lingzhi
Hu, Jian
Li, Houmin
Zhang, Jianzhong
author_facet Li, Tingting
Zhang, Xiaoyue
Wang, Caroline
Jia, Qiuyu
Zhong, Lingzhi
Hu, Jian
Li, Houmin
Zhang, Jianzhong
author_sort Li, Tingting
collection PubMed
description
format Online
Article
Text
id pubmed-10617823
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106178232023-11-05 Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma Li, Tingting Zhang, Xiaoyue Wang, Caroline Jia, Qiuyu Zhong, Lingzhi Hu, Jian Li, Houmin Zhang, Jianzhong Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-11-05 2023-04-10 /pmc/articles/PMC10617823/ /pubmed/37036897 http://dx.doi.org/10.1097/CM9.0000000000002599 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Correspondence
Li, Tingting
Zhang, Xiaoyue
Wang, Caroline
Jia, Qiuyu
Zhong, Lingzhi
Hu, Jian
Li, Houmin
Zhang, Jianzhong
Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma
title Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma
title_full Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma
title_fullStr Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma
title_full_unstemmed Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma
title_short Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma
title_sort development and validation of an m6a rna methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617823/
https://www.ncbi.nlm.nih.gov/pubmed/37036897
http://dx.doi.org/10.1097/CM9.0000000000002599
work_keys_str_mv AT litingting developmentandvalidationofanm6arnamethylationregulatorbasedsignatureforthepredictionofprognosisandimmunotherapyincutaneousmelanoma
AT zhangxiaoyue developmentandvalidationofanm6arnamethylationregulatorbasedsignatureforthepredictionofprognosisandimmunotherapyincutaneousmelanoma
AT wangcaroline developmentandvalidationofanm6arnamethylationregulatorbasedsignatureforthepredictionofprognosisandimmunotherapyincutaneousmelanoma
AT jiaqiuyu developmentandvalidationofanm6arnamethylationregulatorbasedsignatureforthepredictionofprognosisandimmunotherapyincutaneousmelanoma
AT zhonglingzhi developmentandvalidationofanm6arnamethylationregulatorbasedsignatureforthepredictionofprognosisandimmunotherapyincutaneousmelanoma
AT hujian developmentandvalidationofanm6arnamethylationregulatorbasedsignatureforthepredictionofprognosisandimmunotherapyincutaneousmelanoma
AT lihoumin developmentandvalidationofanm6arnamethylationregulatorbasedsignatureforthepredictionofprognosisandimmunotherapyincutaneousmelanoma
AT zhangjianzhong developmentandvalidationofanm6arnamethylationregulatorbasedsignatureforthepredictionofprognosisandimmunotherapyincutaneousmelanoma